FDA Approved: DAPTOMYCIN — Supplemental Application (Civica, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Daptomycin from Civica, Inc., approving an update to its labeling or indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Complicated Skin and Skin Structure Infections
• Infective Endocarditis

Drugs mentioned

• Daptomycin (daptomycin)

Snippet

SUPPL AP for DAPTOMYCIN (DAPTOMYCIN)